Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHA:600866)
China · Delayed Price · Currency is CNY 7.83
+0.24 (3.16%)
At close: Mar 6, 2026
SHA:600866 Market Cap
SHA:600866 has a market cap or net worth of 13.01 billion as of March 6, 2026. Its market cap has increased by 17.92% in one year.
Market Cap
13.01B
Enterprise Value
15.99B
Revenue
16.62B
Ranking
n/a
PE Ratio
10.15
Stock Price
7.83
Market Cap Chart
Since August 25, 2006, SHA:600866's market cap has increased from 1.16B to 13.01B, an increase of 1,019.51%. That is a compound annual growth rate of 13.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 13.01B | 12.66% |
| Dec 31, 2025 | 11.55B | 7.42% |
| Dec 31, 2024 | 10.75B | 38.84% |
| Dec 29, 2023 | 7.74B | -21.42% |
| Dec 30, 2022 | 9.85B | 113.65% |
| Dec 31, 2021 | 4.61B | 25.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inner Mongolia Furui Medical Science | 14.76B |
| Tibet Cheezheng Tibetan Medicine | 14.51B |
| Pacific Shuanglin Bio-pharmacy | 13.16B |
| Vcanbio Cell & Gene Engineering Corp., | 12.81B |
| Mabwell (Shanghai) Bioscience | 12.53B |
| Chengdu Olymvax Biopharmaceuticals | 11.88B |
| Staidson (Beijing) BioPharmaceuticals | 11.66B |
| InventisBio | 11.55B |